Etodolac

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID4451
Ligand NameEtodolac
PubMed Compound Id3308
StructureProduct Image
Molecular FormulaC17H21NO3
Molecular Weight287.35
SMILESCCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
Synonymsetodolac
41340-25-4
Etodolic acid
Lodine XL
Etodolaco
Edolan
Etodolacum
Tedolan
Zedolac
Eccoxolac
Flancox
Napilac
Lodin xl
Etodolacum [INN-Latin]
Etodolaco [INN-Spanish]
(rs)-etodolic acid
CCRIS 3923
1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-
NSC 282126
NSC-282126
CHEBI:4909
DTXSID9020615
Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-
NIH-9918
NSC282126
UNII-2M36281008
DTXCID30615
AY-24-236
Etodolac [USAN:USP:INN:BAN]
(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid
(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
2M36281008
Etodolacum (INN-Latin)
Etodolaco (INN-Spanish)
ETODOLAC (MART.)
ETODOLAC [MART.]
Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-
ETODOLAC (USP-RS)
ETODOLAC [USP-RS]
ETODOLAC (EP MONOGRAPH)
ETODOLAC [EP MONOGRAPH]
ETODOLAC (USP MONOGRAPH)
ETODOLAC [USP MONOGRAPH]
Etodolac (USAN:USP:INN:BAN)
1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid
1,8-DIETHYL-1,3,4,9-TETRAHYDROPYRANO(3,4-B)INDOL-1-ACETIC ACID
Etodolsaure
EtodolacER
1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-ylacetic acid
EtoGesic Tablets
(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano(3,4-b)indol-1-yl)-acetic acid
(1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-yl)acetic acid
M01AB08
Etogesic Sterile Injectable Solution
Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-(+-)-
2-((1RS)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-yl)acetic acid
(+-)-etodolac
Lodine
Ultradol
Ramodar
rac-Etodolac
AY-24236
AY-24,236
AY 24236
2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
MFCD00133313
CHEMBL622
2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
2-{1,8-diethyl-1H,3H,4H,9H-pyrano[3,4-b]indol-1-yl}acetic acid
(+/-)-ETODOLAC
MLS000028474
SMR000058443
(+/-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
(RS)-2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
Hypen
PYRANO(3,4-B)INDOLE-1-ACETIC ACID, 1,8-DIETHYL-1,3,4,9-TETRAHYDRO-(+/-)-
SR-01000000100
Etogesic
Osteluc
etodolac o
rac Etodolac
Etodlic Acid
Lodine SR
RAK-591
NCGC00016849-01
Prestwick_209
CAS-41340-25-4
Etodolac (Standard)
Lodine (TN)
Etodolac Assay Standard
Spectrum_001244
ETODOLAC [USAN]
ETODOLAC [INN]
ETODOLAC [JAN]
ETODOLAC [MI]
ETODOLAC [VANDF]
Opera_ID_1774
Prestwick0_000231
Prestwick1_000231
Prestwick2_000231
Prestwick3_000231
Spectrum2_001387
Spectrum3_001429
Spectrum4_000410
Spectrum5_001347
ETODOLAC [WHO-DD]
SCHEMBL3903
Lopac0_000479
BSPBio_000301
BSPBio_003138
KBioGR_000680
KBioSS_001724
Etodolac - Bio-X trade mark
MLS001077315
MLS006011566
DivK1c_000147
ETODOLAC [GREEN BOOK]
SPECTRUM1501005
Etodolac (JP18/USP/INN)
SPBio_001374
SPBio_002222
ETODOLAC [ORANGE BOOK]
BPBio1_000333
GTPL7185
Etodolac for peak identification
HMS500H09
KBio1_000147
KBio2_001724
KBio2_004292
KBio2_006860
KBio3_002358
NINDS_000147
HMS1568P03
HMS1921B09
HMS2092O20
HMS2095P03
HMS2231D04
HMS3259P10
HMS3261O20
HMS3374G09
HMS3712P03
Pharmakon1600-01501005
BBC19746
BCP28411
Tox21_110644
Tox21_202218
Tox21_500479
1,8-diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic acid
BDBM50016799
CCG-39005
HY-76251R
NSC757821
AKOS015838610
Tox21_110644_1
AC-4231
CS-0832
DB00749
FR27516
LP00479
NC00718
NSC-757821
SDCCGSBI-0050463.P004
IDI1_000147
NCGC00015399-03
NCGC00015399-04
NCGC00015399-05
NCGC00015399-06
NCGC00015399-07
NCGC00015399-08
NCGC00015399-09
NCGC00015399-11
NCGC00015399-12
NCGC00015399-13
NCGC00015399-15
NCGC00015399-16
NCGC00015399-26
NCGC00015399-27
NCGC00089769-02
NCGC00089769-03
NCGC00089769-04
NCGC00089769-05
NCGC00089769-06
NCGC00089769-07
NCGC00259767-01
NCGC00261164-01
BR164431
HY-76251
SY057989
SBI-0050463.P003
AB00052194
E0858
EU-0100479
NS00010209
C06991
D00315
E 0516
EN300-119494
Pyrano[3, 1,8-diethyl-1,3,4,9-tetrahydro-
AB00052194_17
Q2465218
SR-01000000100-2
SR-01000000100-4
SR-01000000100-7
BRD-A74667430-001-05-3
BRD-A74667430-001-15-2
BRD-A74667430-001-23-6
1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid
Etodolac, European Pharmacopoeia (EP) Reference Standard
F2173-0681
Z1521549186
Etodolac, United States Pharmacopeia (USP) Reference Standard
1,8-Diethyl-1,3,4,9-tetrahydropyranol[3,4-b]indole-1-acetic acid
Pyrano(3,4,b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;(+/-)-Etodolac
AY 24,236; AY 24236;AY-24,236; AY-24236; AY24,236; AY24236
Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard
1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;(RS)-Etodolic acid;(+/-)-Etodolac
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm